Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -37.4% | -33.3% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.3 | 1.8 |
Pr/Book | 0.8 |
Latest | F'cast | |
---|---|---|
Revenue | -13.5% | 4.1% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-20 | 9.53 | 0.86 | 2.02p | 48.0 | 0.4 | +120% | n/a | 0.0% |
30-Sep-21 | 9.19 | 1.10 | 3.17p | 25.2 | 0.4 | +57% | n/a | 0.0% |
30-Sep-22 | 8.64 | 0.88 | 2.14p | 15.7 | n/a | -32% | n/a | 0.0% |
30-Sep-23 | 6.66 | (1.36) | (2.44)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-24 | 5.77 | (2.09) | (4.14)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-25 | 6.00 | (2.00) | (2.10)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Contract Win | 27-Feb-2025 | 07:00 | RNS |
Further Validation of IXICO’s AI Imaging P... | 12-Feb-2025 | 07:00 | RNS |
Issue of share options and PDMR dealing | 07-Feb-2025 | 15:00 | RNS |
One to watch: Phytopharm | 19-Jul-2011 | The Scotsman |
Phytopharm soars 340% on drug trial | 15-Oct-2009 | The Independent |
Need to know: InBev go ahead ... Citigroup job c... | 15-Nov-2008 | Times |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 8.19p |
Change Today | -0.063p |
% Change | -0.76 % |
52 Week High | 12.75 |
52 Week Low | 6.45 |
Volume | 349 |
Shares Issued | 92.67m |
Market Cap | £7.59m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research